CRA was retained to assess claims of “healthy antioxidants” associated with consumer products. CRA examined manufacturer pricing data and industry practice with respect to whether such claims affected prices or sales. CRA exploited variation in labeling across products and over time to examine Plaintiffs’ allegations and proposed methods to compute consumer harm.
Price-gouging or normal market functioning amid COVID-19?
The progression of COVID-19 into a global pandemic and measures taken to flatten the curve have resulted in severe economic disruptions. Illness-winnowed...